The Reuters News Agency reported on January 3 that the Federal Drug Administration had granted the Advanced Cell Technology (ACT) firm the right to try out using embryonic stem cells for treating macular degeneration, a common cause of blindness. ACT’s chief scientific officer, Dr. Robert Lanza, said that ACT would immediately recruit patients with age related macular degeneration and would use stem cells procured by destroying embryonic human beings in an effort to help these patients retain or recover their vision.Article: Culture of Life
This essay will first explain what macular degeneration is and note its different forms. It will then focus on the morality of using human embryonic stem cells in efforts to cure persons suffering from maladies, and then report and reflect on relevant scientific evaluations of the therapeutic value efficacy of embryonic stem cell research.
Friday, January 14, 2011
Macular Degeneration and Human Embryonic Stem Cells
by William E. May, Ph.D., Senior Fellow